Brooks Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 153.03 million compared to INR 190.08 million a year ago. Revenue was INR 153.95 million compared to INR 193.76 million a year ago. Net loss was INR 50.19 million compared to INR 66.11 million a year ago. Basic loss per share from continuing operations was INR 2.03 compared to INR 2.68 a year ago. Diluted loss per share from continuing operations was INR 2.03 compared to INR 2.68 a year ago.
For the nine months, sales was INR 505.08 million compared to INR 626.15 million a year ago. Revenue was INR 507.71 million compared to INR 633.41 million a year ago. Net loss was INR 166.02 million compared to INR 125.85 million a year ago. Basic loss per share from continuing operations was INR 6.72 compared to INR 5.09 a year ago. Diluted loss per share from continuing operations was INR 6.72 compared to INR 5.09 a year ago.